The Company and Nature of Business (Details)			1 Months Ended	12 Months Ended
	Feb. 12, 2018 shares	Nov. 10, 2010 shares	Jan. 26, 2021 shares	Dec. 31, 2021 shares	Jun. 04, 2021 shares
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued			35,644,997
Common stock outstanding percentage			80.00%
Series C convertible preferred stock					101,015,049
Common Stock [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued				4,700
Exercisable shares of common stock			2,124,687
Series C Convertible Preferred Stock [Member]
The Company and Nature of Business (Details) [Line Items]
Series C convertible preferred stock			1,000,000
RSU [Member]
The Company and Nature of Business (Details) [Line Items]
Exercisable shares of common stock			5,718,838
Agreement and Plan of Merger [Member] | Boston Therapeutics, Inc. [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued		4,000,000
Common stock outstanding percentage		100.00%
Contribution Agreement [Member] | CureDM Group Holdings, LLC [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued	47,741,140
Number of shares issued at time of delivered	25,000,000
Number of shares issued at time of milestones	22,741,140
Number of tranches for delivered | Tranches	4
Number of shares issued per tranches	5,685,285